Owens & Minor ( (OMI) ) has shared an announcement.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Owens & Minor reported a 5% rise in third-quarter revenue to $2.7 billion, driven by robust demand in Patient Direct and Medical Distribution. Despite a GAAP net loss of $13 million, adjusted earnings per share stood at $0.42. The company significantly reduced its debt by nearly $200 million, bolstering its financial position. Looking ahead, Owens & Minor anticipates sequential growth and improved cash flow, aiming for a revenue range of $10.6 to $10.8 billion for 2024.
Find detailed analytics on OMI stock on TipRanks’ Stock Analysis page.
